dc.contributor.author
Backes, Christina
dc.contributor.author
Haas, Jan
dc.contributor.author
Leidinger, Petra
dc.contributor.author
Frese, Karen
dc.contributor.author
Großmann, Thomas
dc.contributor.author
Ruprecht, Klemens
dc.contributor.author
Meder, Benjamin
dc.contributor.author
Meese, Eckart
dc.contributor.author
Keller, Andreas
dc.date.accessioned
2018-06-08T03:16:31Z
dc.date.available
2015-08-25T05:33:39.740Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/14826
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-19015
dc.description.abstract
Background While in the past decades nucleic acid analysis has been
predominantly carried out using quantitative low- and high-throughput
approaches such as qRT-PCR and microarray technology, next-generation
sequencing (NGS) with its single base resolution is now frequently applied in
DNA and RNA testing. Especially for small non-coding RNAs such as microRNAs
there is a need for analysis and visualization tools that facilitate
interpretation of the results also for clinicians. Methods We developed
miFRame, which supports the analysis of human small RNA NGS data. Our tool
carries out different data analyses for known as well as predicted novel
mature microRNAs from known precursors and presents the results in a well
interpretable manner. Analyses include among others expression analysis of
precursors and mature miRNAs, detection of novel precursors and detection of
potential iso-microRNAs. Aggregation of results from different users moreover
allows for evaluation whether remarkable results, such as novel mature miRNAs,
are indeed specific for the respective experimental set-up or are frequently
detected across a broad range of experiments. Results We demonstrate the
capabilities of miFRame, which is freely available at http://www.ccb.uni-
saarland.de/miframe on two studies, circulating biomarker screening for
Multiple Sclerosis (cohort includes clinically isolated syndrome, relapse
remitting MS, matched controls) as well as Alzheimer Disease (cohort includes
Alzheimer Disease, Mild Cognitive Impairment, matched controls). Here, our
tool allowed for an improved biomarker discovery by identifying likely false
positive marker candidates.
en
dc.rights.uri
http://creativecommons.org/licenses/by/4.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::616 Krankheiten
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
Journal of Translational Medicine. - 13 (2015), 1, Artikel Nr. 224
dc.title.subtitle
analysis and visualization of miRNA sequencing data in neurological disorders
dcterms.bibliographicCitation.doi
10.1186/s12967-015-0594-x
dcterms.bibliographicCitation.url
http://www.translational-medicine.com/content/13/1/224
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000022962
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000005301
dcterms.accessRights.openaire
open access